Organization profile

Organisation profile

As Western Australia’s premier adult medical research institute our priority is to recruit and build internationally renowned highly skilled research teams, comprising doctors, scientists, biostatisticians and pathologists, working together with cutting edge technologies to make new discoveries and translate this new knowledge into more effective treatments and cures. 

Closely linked to the major teaching hospitals, we are uniquely positioned to fast track the development of new treatments and new ways to diagnose cancer and other diseases, including tests that enable doctors to select the best approach for each patient.  This enhances our ability to match individual patients to the treatments most likely to work for them with the aim of making personalised treatment a reality at last. 

The University of Western Australia, Royal Perth Hospital and Sir Charles Gairdner Hospital were our founding partners and in July 2003, Fremantle Hospital also became a partner.

To view our publications visit the Institute's website via the link provided in Contact Information.

Fingerprint The fingerprint is based on mining the text of the scientific documents related to the associated persons. Based on that an index of weighted terms is created, which defines the key subjects of research unit

Mutation Medicine & Life Sciences
Proteins Medicine & Life Sciences
Genes Medicine & Life Sciences
Hospital Emergency Service Medicine & Life Sciences
Long Noncoding RNA Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
MicroRNAs Medicine & Life Sciences
Genome Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2004 2019

1 Citation (Scopus)

A collaborative analysis of individual participant data from 19 prospective studies assesses circulating Vitamin D and prostate cancer risk

Endogenous Hormones, Nutritional Biomarkers and Prostate Cancer Collaborative Group, 1 Jan 2019, In : Cancer Research. 79, 1, p. 274-285 12 p.

Research output: Contribution to journalArticle

1 Citation (Scopus)

Activating PTEN Tumor Suppressor Expression with the CRISPR/dCas9 System

Moses, C., Nugent, F., Waryah, C. B., Garcia-Bloj, B., Harvey, A. R. & Blancafort, P., 1 Mar 2019, In : Molecular Therapy - Nucleic Acids. 14, p. 287-300 14 p.

Research output: Contribution to journalArticle

Open Access
Clustered Regularly Interspaced Short Palindromic Repeats
Melanoma
Triple Negative Breast Neoplasms
Phosphatidylinositol 3-Kinases
Epigenetic Repression

Advanced Genetic Approaches in Discovery and Characterization of Genes Involved With Osteoporosis in Mouse and Human

Yuan, J., Tickner, J., Mullin, B. H., Zhao, J., Zeng, Z., Morahan, G. & Xu, J., 2 Apr 2019, In : Frontiers in Genetics. 10, 13 p., 288.

Research output: Contribution to journalReview article

Open Access